Document Detail


Effects of vitreomacular adhesion on ranibizumab treatment in Japanese patients with age-related macular degeneration.
MedLine Citation:
PMID:  25096269     Owner:  NLM     Status:  Publisher    
Abstract/OtherAbstract:
PURPOSE: To investigate the effects of vitreomacular adhesion (VMA) on intravitreal ranibizumab treatment in Japanese patients with exudative age-related macular degeneration (AMD).
METHODS: This was a retrospective comparative study that included 123 eyes from 123 patients with exudative AMD. The presence or absence of VMA was examined by spectral domain optical coherence tomography. The association of VMA with best-corrected visual acuity (BCVA) and central retinal thickness (CRT) at 3, 6, and 12 months after ranibizumab treatment was evaluated.
RESULTS: In the group of eyes without VMA [VMA(-)], the mean BCVA was 0.41 logMAR at baseline and significantly improved to 0.28, 0.30, and 0.29 logMAR at 3, 6, and 12 months following the initiation of treatment (P < 0.0001, <0.0001, <0.0001), respectively. In the group of eyes with VMA [VMA(+)], the mean BCVA was 0.42 logMAR at baseline, and there was no improvement at any of the measurement time-points during the follow-up period [0.39, 0.40, and 0.39 logMAR at 3, 6, and 12 months (P = 0.53, 0.75, 0.67), respectively]. The mean baseline CRT in the VMA(-) and VMA(+) groups was 326 and 370 µm, respectively, decreasing to 195 and 293 µm (P < 0.0001 and P = 0.0070), respectively, at 12 months. A better baseline BCVA was associated with poor visual response to intravitreal ranibizumab.
CONCLUSIONS: Our study of Japanese patients with AMD managed in real-world clinical practice revealed that both VMA and BCVA at baseline were associated with a poor visual response to intravitreal ranibizumab. These results are in agreement with previously reported findings for other ethnic groups.
Authors:
Yoko Nomura; Hidenori Takahashi; Xue Tan; Shigeto Fujimura; Ryo Obata; Yasuo Yanagi
Related Documents :
24796489 - A case of lichen planus pigmentosus that was recalcitrant to topical treatment respondi...
23472009 - Prestorage in ovo injection of biological buffers: an approach to improve hatchability ...
25069999 - Treatment of lower extremity telangiectasias in women by foam sclerotherapy vs. nd:yag ...
23351389 - Neural stem cell-like cells derived from autologous bone mesenchymal stem cells for the...
24971149 - Modulation of cardiac autonomic dysfunction in ischemic stroke following ayurveda (indi...
24756009 - Treatment with metadoxine and its impact on early mortality in patients with severe alc...
25168539 - Hyperuricemia: a possible cause of hemospermia.
21067429 - Time-dependent improvement in functional outcome following lcs rotating platform knee r...
14563499 - Comparison of four clinical prediction scores for the diagnosis of lower limb deep veno...
Publication Detail:
Type:  JOURNAL ARTICLE     Date:  2014-8-6
Journal Detail:
Title:  Japanese journal of ophthalmology     Volume:  -     ISSN:  1613-2246     ISO Abbreviation:  Jpn. J. Ophthalmol.     Publication Date:  2014 Aug 
Date Detail:
Created Date:  2014-8-6     Completed Date:  -     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  0044652     Medline TA:  Jpn J Ophthalmol     Country:  -    
Other Details:
Languages:  ENG     Pagination:  -     Citation Subset:  -    
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Use of addiction treatment services by Irish youth: does place of residence matter?
Next Document:  A novel exon 17 deletion mutation of RPGRIP1 gene in two siblings with Leber congenital amaurosis.